IERVASI, ERIKA
 Distribuzione geografica
Continente #
EU - Europa 2.003
AS - Asia 510
NA - Nord America 438
Continente sconosciuto - Info sul continente non disponibili 88
SA - Sud America 50
AF - Africa 8
OC - Oceania 1
Totale 3.098
Nazione #
IT - Italia 1.936
US - Stati Uniti d'America 402
SG - Singapore 213
CN - Cina 109
VN - Vietnam 93
BD - Bangladesh 34
BR - Brasile 33
FR - Francia 21
HK - Hong Kong 16
CA - Canada 15
IN - India 8
MX - Messico 8
AR - Argentina 7
DE - Germania 7
IQ - Iraq 7
GB - Regno Unito 6
NL - Olanda 6
FI - Finlandia 5
ID - Indonesia 5
PL - Polonia 5
CO - Colombia 3
CR - Costa Rica 3
ES - Italia 3
JP - Giappone 3
KE - Kenya 3
MY - Malesia 3
NP - Nepal 3
PK - Pakistan 3
TT - Trinidad e Tobago 3
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
LT - Lituania 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
AT - Austria 1
AW - Aruba 1
BB - Barbados 1
BE - Belgio 1
EC - Ecuador 1
EG - Egitto 1
GR - Grecia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RO - Romania 1
SE - Svezia 1
SI - Slovenia 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
TW - Taiwan 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.011
Città #
Genoa 1.176
Genova 355
Vado Ligure 206
Rapallo 112
Singapore 112
San Jose 100
Ashburn 60
Ho Chi Minh City 33
Hanoi 23
Council Bluffs 22
Beijing 20
Lauterbourg 16
Hong Kong 14
New York 11
Santa Clara 11
Bordighera 10
Rome 10
Los Angeles 9
Montreal 7
Naples 7
Boardman 6
Brescia 6
Da Nang 5
Frankfurt am Main 5
Haiphong 5
Helsinki 5
Mexico City 5
Buffalo 4
Milan 4
Phoenix 4
Turin 4
Amsterdam 3
Anchorage 3
Baghdad 3
Basra 3
Chennai 3
Chicago 3
City of London 3
Dallas 3
North Charleston 3
Padua 3
Quảng Ngãi 3
San José 3
São Paulo 3
Taranto 3
Tokyo 3
Albany 2
Alpharetta 2
Atlanta 2
Birmingham 2
Cape Coral 2
Columbia 2
Curitiba 2
Guatemala City 2
Hải Dương 2
Kingston 2
Lahore 2
Lyndhurst 2
Madrid 2
Marseille 2
Medellín 2
Messina 2
Montgomery 2
Mumbai 2
Orem 2
Petaling Jaya 2
Piscataway 2
Plant City 2
Princeton 2
Rutigliano 2
Sacramento 2
San Francisco 2
South Jordan 2
Tampa 2
Tel Aviv 2
The Bronx 2
Toronto 2
Warsaw 2
Washington 2
Zurich 2
Abbeville 1
Amman 1
Apodaca 1
Araruama 1
Arlington 1
Ashland 1
Asunción 1
Athens 1
Bang Lamung 1
Banyuwangi 1
Barbacena 1
Barnet 1
Barranquilla 1
Bel Air 1
Bellingham 1
Belo Horizonte 1
Bengaluru 1
Bento Gonçalves 1
Biên Hòa 1
Bolton 1
Totale 2.500
Nome #
A multi-omics approach reveals impaired lipid metabolism and oxidative stress in a zebrafish model of Alexander disease 171
Anti-inflammatory and stress responses after intense vs moderate judo exercise in children 169
Correlazione dei livelli sierici di IL-21 con autoanticorpi IgA anti -tTG e danno mucosale in pazienti affetti da malattia celiaca 166
Evaluation of neuroendocrine parameters during osteopathic manipulative treatment (OMT) 161
Hypothalamic expression of PD-L1: does it mediate hypothalamitis? 149
Insights into the Pharmacological Activity of the Imidazo-Pyrazole Scaffold 145
FRI0480 CHANGES IN CIRCULATING SCTLA-4 FOLLOWING ZOLEDRONIC ACID INFUSION 141
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells 132
Regioselective Synthesis, Structural Characterization, and Antiproliferative Activity of Novel Tetra-Substituted Phenylaminopyrazole Derivatives 130
Cyclic diacyl thioureas enhance activity of corrector Lumacaftor on F508del‐CFTR 122
One-Pot Synthesis and Antiproliferative Activity of Highly Functionalized Pyrazole Derivatives 121
Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology 113
Two calix[4]pyrroles as potential therapeutics for castration-resistant prostate cancer 111
Circulating anti-hypothalamus antibodies in celiac patients: tissue transglutaminase friend or foe? 109
Structure–Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents 105
Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor 100
Serum IL-21 levels from celiac disease patients correlates with anti-tTG IgA autoantibodies and mucosal damage 97
Zoledronate decreases CTLA-4 in vivo and in vitro independently of its action on bone resorption 94
Antioxidant properties of Knoevenagel-type indoles 89
Multiple approaches reveal altered lipid metabolism, neurotransmitter release and nervous conduction in a zebrafish model of Alexander Disease 87
Novel 5-aminopyrazoles endowed with anti-angiogenetic properties: Design, synthesis and biological evaluation 84
Novel tetrasubstituted 5-Arylamino pyrazoles able to interfere with angiogenesis and Ca2+ mobilization 72
Regioselective synthesis and structural characterization of novel tri- and tetra- substituted anilino pyrazoles endowed with antimalarial activity 69
Novel 5-arylamino pyrazoles able to interfere with angiogenesis and Ca2+ homeostasis 67
Diversity-oriented synthesis of novel heterocyclic compounds and their preliminary evaluation as antimalarial agents 62
STRUCTURAL FUNCTIONALIZATION OF TRI-SUBSTITUTED PYRAZOLE DERIVATIVES AND PRELIMINARY EVALUATION OF THEIR ANTIMALARIAL ACTIVITY 61
Antiprotozoal Activity of Highly Substituted Pyrazole and Pyrimidine Derivatives 56
Beyond translation: systematic insight of the multifaceted roles of GARS1 in cellular biology and disease 52
Targeting Ubiquitin‐Specific Protease 7 with Novel 5‐Amino‐Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation 45
null 18
Totale 3.098
Categoria #
all - tutte 10.434
article - articoli 7.530
book - libri 0
conference - conferenze 2.463
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.427


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202295 5 4 4 5 4 7 2 22 17 10 1 14
2022/2023141 9 14 2 5 18 19 11 9 24 1 22 7
2023/2024229 2 21 12 27 16 14 17 29 10 12 29 40
2024/2025706 22 36 28 49 58 49 63 119 54 44 111 73
2025/20261.529 145 65 154 115 189 67 177 95 166 182 89 85
2026/2027119 119 0 0 0 0 0 0 0 0 0 0 0
Totale 3.098